Bio Protocol / USDC
0.096
04-March-25 08:46:17
realtime
Instruments
-0.008
-7.69%
Today's range
0.0895 - 0.1042
ISIN
FXBIOUSDC
Source
BINCE
-
Telsey Advisory Group Reaffirms Outperform Rating for ThredUp (NASDAQ:TDUP)
04 Mar 2025 08:01:13 By Buzz FX
-
D. Boral Capital Initiates Coverage on Tevogen Bio (NASDAQ:TVGN)
04 Mar 2025 08:01:13 By Buzz FX
-
Protagonist Therapeutics (NASDAQ:PTGX) Price Target Raised to $57.00 at JPMorgan Chase & Co.
04 Mar 2025 08:01:13 By Buzz FX
-
ON (NYSE:ONON) Releases Earnings Results, Beats Expectations By $0.11 EPS
04 Mar 2025 08:01:13 By Buzz FX
-
Microchip Technology (NASDAQ:MCHP) Price Target Raised to $68.00
04 Mar 2025 08:01:13 By Buzz FX
-
Pliant Therapeutics (NASDAQ:PLRX) Earns Hold Rating from Needham & Company LLC
04 Mar 2025 08:01:13 By Buzz FX
-
Illumina (NASDAQ:ILMN) Given New $90.00 Price Target at Citigroup
04 Mar 2025 08:01:13 By Buzz FX
-
Target highlights slowdown in US consumer spending
04 Mar 2025 08:00:22 By Buzz FX
-
Trump trades are upended as Treasury returns beat U.S. stocks
04 Mar 2025 07:51:15 By Buzz FX
-
Aussie housing market heats up following interest rate cut
04 Mar 2025 07:49:23 By Buzz FX
-
Acelyrin, Inc. (NASDAQ:SLRN) Sees Large Decrease in Short Interest
04 Mar 2025 07:49:15 By Buzz FX
-
Barclays Has Lowered Expectations for Fortrea (NASDAQ:FTRE) Stock Price
04 Mar 2025 07:49:15 By Buzz FX
-
Rosenblatt Securities Reaffirms "Buy" Rating for Canaan (NASDAQ:CAN)
04 Mar 2025 07:49:15 By Buzz FX
-
HC Wainwright Reaffirms Buy Rating for Ocular Therapeutix (NASDAQ:OCUL)
04 Mar 2025 07:49:15 By Buzz FX
-
Medtronic (NYSE:MDT) Rating Increased to Buy at Citigroup
04 Mar 2025 07:49:15 By Buzz FX
-
Hawaiian Electric Industries (NYSE:HE) Stock Price Expected to Rise, Barclays Analyst Says
04 Mar 2025 07:49:15 By Buzz FX
-
Scotts Miracle-Gro (NYSE:SMG) Upgraded by Stifel Nicolaus to Buy Rating
04 Mar 2025 07:49:15 By Buzz FX
-
Chart Industries (NYSE:GTLS) Price Target Raised to $165.00
04 Mar 2025 07:49:15 By Buzz FX
-
Frontier Group (NASDAQ:ULCC) Lowered to Hold Rating by Deutsche Bank Aktiengesellschaft
04 Mar 2025 07:49:15 By Buzz FX
-
Needham & Company LLC Reaffirms "Buy" Rating for Neumora Therapeutics (NASDAQ:NMRA)
04 Mar 2025 07:49:15 By Buzz FX